Camille is a biotech executive and entrepreneur, and Head of Biotechnology at Verb Biotics, where he leads GM activities for microbiome health, in collaboration with Ginkgo and additional partners. Camille holds a PhD in synthetic biology from Paris Descartes University and conducted his thesis research at Harvard University.